Treatment of Hartnup disease with nicotinic acid.
D002524:Cerebellar Ataxia / Q000188:drug therapy; D002648:Child; D005260:Female; D006250:Hartnup Disease / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D008297:Male; D009525:Niacin / Q000096:biosynthesis / Q000627:therapeutic use*; D009536:Niacinamide / Q000627:therapeutic use*; D010383:Pellagra / Q000188:drug therapy; D014364:Tryptophan / Q000378:metabolism
D009536:Niacinamide; D009525:Niacin; D014364:Tryptophan